Sodium Hyaluronate Eye Drops Market Share

Sodium Hyaluronate Eye Drops Market Overview

The Sodium Hyaluronate Eye Drops Market Size was valued at USD 0.25 Billion in 2022 and is projected to grow from USD 0.29 Billion in 2023 to USD 0.41 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.9% during the forecast period (2023 - 2032). Due to stinging, burning or scratchy sensation in eyes and rising incidence of dry eye syndrome are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sodium Hyaluronate Eye Drops Market Trends

Rising incidences for eye irritation is driving the market growth

The market for sodium hyaluronate eye drops is expanding significantly, partly due to the rising incidence of people experiencing stinging, burning, and scratchy feelings in their eyes. These unpleasant feelings are frequently signs of a number of underlying eye diseases, such as dry eye syndrome, allergies, and environmental factors. As a result, patients frequently turn to sodium hyaluronate eye drops to provide effective and rapid relief.

The rising incidence of dry eye disease is one of the main causes of the spike in demand for sodium hyaluronate eye drops. Due to variables like extended screen time, frequent use of digital gadgets, and shifting environmental circumstances, this syndrome has become more and more prevalent. More people are consequently reporting symptoms like stinging, burning, and a gritty sensation in their eyes. The irritation caused by dry eyes is especially addressed with sodium hyaluronate eye drops. They function by having a lubricating and relaxing effect on the eyes, which relieves these uncomfortable feelings and offers much-needed relief.

Another significant factor in the rising market demand for sodium hyaluronate eye drops is allergies. Eyes that are red, itchy, and watery with a burning feeling are common symptoms of allergic responses. To alleviate these uncomfortable symptoms, allergy patients frequently use antihistamine eye drops, many of which contain sodium hyaluronate. To meet the demands of people looking for prompt relief from allergy-related eye irritation, this market segment has rapidly developed.

Environmental aspects can significantly influence the market. The eyes may feel scratchy or burning due to environmental irritants such dust, smoke, pollen, and other substances. These irritants are more common in urban areas with high pollution levels or areas with unfavorable environmental conditions. People are turning more frequently to eye drops as an easy and quick remedy to lessen these effects. With its moisturizing qualities, sodium hyaluronate eye drops can assist remove irritants and offer much-needed relief from the discomfort brought on by environmental causes.

Another important factor driving the market for sodium hyaluronate eye drops is the ease of over the counter eye drops. These products are easily accessible at pharmacies, grocery stores, and online merchants, allowing people to quickly and without a prescription alleviate eye irritation. The mild and excellent moisturizing action of sodium hyaluronate eye drops has made them popular among customers looking for quick and convenient relief. Thus, driving the Sodium hyaluronate eye drops market revenue.

Sodium Hyaluronate Eye Drops Market Segment Insights

Sodium Hyaluronate Eye Drops Type Insights

The Sodium Hyaluronate Eye Drops Market segmentation, based on type, includes 0.001, 0.0015, 0.003 and others. The 0.0015 segment dominated the market in 2022. The 0.0015 sodium hyaluronate eye drops may be particularly beneficial for treating severe dry eye conditions. This concentration is preferred by both patients and medical practitioners since it can provide longer persistent comfort and increased hydration for those with more severe symptoms.

Sodium Hyaluronate Eye Drops Applications Insights

The Sodium Hyaluronate Eye Drops Market segmentation, based on applications, includes dry eye, rewetting and others. The dry eye category generated the most income in 2022. The prevalence of dry eye syndrome has increased as individuals spend more time in front of screens, whether for work or recreation. Consider a working professional who uses a computer for a significant portion of each day. Digital eye strain, a major cause of dry eyes, can result from spending too much time on screens. This person may use sodium hyaluronate eye drops to treat their symptoms of dry eyes.

Figure 1: Sodium Hyaluronate Eye Drops Market, by Applications, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Sodium Hyaluronate Eye Drops Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Sodium Hyaluronate Eye Drops Market dominated this market in 2022 (45.80%). The market for sodium hyaluronate eye drops in the US is significantly influenced by the aging baby boomer generation. These people are more vulnerable to age-related dry eye condition as they get older. Think about a 70-year-old retiree who has chronic symptoms of dry eyes. They contact an ophthalmologist in search of relief, who suggests sodium hyaluronate eye drops as a component of their treatment strategy. The demand for these eye drops is fueled by the magnitude of the aging population in North America. Further, the U.S. Sodium hyaluronate eye drops market held the largest market share, and the Canada Sodium hyaluronate eye drops market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: SODIUM HYALURONATE EYE DROPS MARKET SHARE BY REGION 2022 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Sodium hyaluronate eye drops market accounts for the second-largest market share. The European Medicines Agency (EMA) maintains strict regulatory requirements for drugs, ensuring that medicines are reliable, efficient, and up to par. This stringent level of regulation fosters confidence in both patients and healthcare professionals. For instance, due to the strict regulatory control, a patient with dry eye disease in Germany is more likely to choose sodium hyaluronate eye drops recommended by a reputable healthcare provider. Sales and market expansion are fueled by this confidence in the quality of the product. Further, the German Sodium hyaluronate eye drops market held the largest market share, and the UK Sodium hyaluronate eye drops market was the fastest growing market in the European region.

The Asia-Pacific Sodium Hyaluronate Eye Drops Market is expected to grow at the fastest CAGR from 2023 to 2032. There is an increase in demand for eye care goods in nations like China and India where huge populations have better access to healthcare facilities. Consider a Chinese middle-class family that now has access to routine eye exams. If a family member is diagnosed with dry eye, they will probably take the sodium hyaluronate eye drops as advised by the ophthalmologist. The Asia Pacific market is expanding due to a big population base and expanding healthcare access. Moreover, China’s Sodium hyaluronate eye drops market held the largest market share, and the Indian Sodium hyaluronate eye drops market was the fastest growing market in the Asia-Pacific region.

Sodium Hyaluronate Eye Drops Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Sodium hyaluronate eye drops market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Sodium hyaluronate eye drops industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Sodium hyaluronate eye drops industry to benefit clients and increase the market sector. In recent years, the Sodium hyaluronate eye drops industry has offered some of the most significant advantages to medicine. Major players in the Sodium hyaluronate eye drops market, including URSAPHARM Arzneimittel GmbH, Santen, Bayer Inc., Bausch and Lomb, Johnson and Johnson, The United Laboratories, Alcon, Novax Pharma, Rohto, Thea Pharmaceuticals, Scope Ophthalmics Ltd, Prestige Consumer Healthcare, Medicom Healthcare Ltd, Altacor, Optrex and others, are attempting to increase market demand by investing in research and development operations.

Santen Pharmaceutical Co Ltd (Santen) focuses primarily on the development, production, and marketing of pharmaceutical products and medical equipment. In addition to over-the-counter medications, Santen also offers prescription ophthalmic products for diseases like glaucoma, bacterial conjunctivitis, dry eye, inflammation, cataract, muscae volitantes, diabetic retinopathy, retinal detachment, hyposphagma, myopia, retinal detachment, amblyopia, astigmatism, strabismus, hordeolum, and VDT syndrome. It has production facilities in Japan, Noto, Shiga, and Suzhou, China. Santen's corporate headquarters are in Osaka-Shi, Osaka, Japan.

Johnson & Johnson (J&J) develops, produces, and markets pharmaceuticals, medical devices, and consumer goods. The company sells consumer goods in the oral care, baby care, beauty, over-the-counter (OTC) medication, women's health, and wound care categories, as well as pharmaceuticals for immunological, cancer, neurological, cardiovascular, and metabolic diseases. The company also sells medical equipment for use in the disciplines of general surgery, orthopaedics, neurovascular, and vision care. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals, and hospitals in addition to selling consumer goods through retail stores and distributors. The company distributes its products not just in the US but also in Europe, Asia-Pacific, Africa, and the Western Hemisphere. J&J's corporate headquarters are located in New Brunswick, New Jersey, a city in the US.

Key Companies in the Sodium Hyaluronate Eye Drops Market Include

• URSAPHARM Arzneimittel GmbH


• Santen


• Bayer Inc.


• Bausch and Lomb


• Johnson and Johnson


• The United Laboratories


• Alcon


• Novax Pharma


• Rohto


• Thea Pharmaceuticals


• Scope Ophthalmics Ltd


• Prestige Consumer Healthcare


• Medicom Healthcare Ltd


• Altacor


• Optrex

Sodium Hyaluronate Eye Drops Industry Developments

April 2022: Bobbi Brown & Jones Road launched "WTF" foundation formulated with jojoba oil, vitamin E, and sodium hyaluronate (a humectant that attracts moisture when applied to the skin)

February 2023: Santen Pharmaceutical announced that China's National Medical Products Administration accepted its application to market STN1011101, a preservative-free combination eye drop for treating open-angle glaucoma and ocular hypertension.

Sodium Hyaluronate Eye Drops Market Segmentation

Sodium Hyaluronate Eye Drops Type Outlook

• 001


• 0015


• 003


• Others

Sodium Hyaluronate Eye Drops Applications Outlook

• Dry Eye


• Rewetting


• Others

Sodium Hyaluronate Eye Drops Regional Outlook

• North America
  
  
  
  • USA
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa